Newsroom-Katalog
Zeit | Grünenthal Group: Meldungen vom 22.05.2023 |
---|---|
10:05 | Grünenthal’s resiniferatoxin receives Breakthrough Therapy Designation from U.S. FDA for pain associated with osteoarthritis of the knee |
Zeit | Grünenthal Group: Meldungen vom 22.05.2023 |
---|---|
10:05 | Grünenthal’s resiniferatoxin receives Breakthrough Therapy Designation from U.S. FDA for pain associated with osteoarthritis of the knee |